Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00273819 · ClinicalTrials.gov registry record · NA

Study of Coronary Artery Disease by Two Types of Angiography

A NA study of Congestive Heart Failure, sponsored by VA Connecticut Healthcare System.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00273819 is a NA study of Congestive Heart Failure that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 30 participants, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00273819, a NA study of Congestive Heart Failure, has completed, sponsored by VA Connecticut Healthcare System.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the ability of a new X-ray technique called CT angiography to identify significant narrowing of the coronary arteries compared to traditional coronary angiogram.

Conditions Studied

Interventions

  • PROCEDURE CT angiography

Study Locations (1)

Connecticut

  • VACT Healthcare System-Yale School of Medicine - West Haven

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2005-10
Est. Completion 2007-06
Phase NA

Sponsor

VA Connecticut Healthcare System

26 total trials

What the Registry Record Tells You About NCT00273819

The ClinicalTrials.gov registry entry for NCT00273819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (91% lower). The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CT angiography is the first listed.

NCT00273819 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00273819 about?

NCT00273819 is a clinical study titled "Study of Coronary Artery Disease by Two Types of Angiography". The purpose of this study is to test the ability of a new X-ray technique called CT angiography to identify significant narrowing of the coronary arteries compared to traditional coronary angiogram.

What is the current status of trial NCT00273819?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2005-10. Estimated completion is 2007-06.

What conditions does trial NCT00273819 study?

This clinical trial studies the following conditions: Congestive Heart Failure.

What interventions are being tested in trial NCT00273819?

The interventions under investigation include: CT angiography (PROCEDURE).

Who is sponsoring clinical trial NCT00273819?

This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00273819 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Congestive Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.